Shanxi Zhendong Ante Biopharmaceutical Co., Ltd., Anteda Feixin, a well-known hair growth brand. It was established in 1994. It mainly focuses on digestive drugs and is a high-tech enterprise specializing in the research, development, production and sales of new drugs.
Shanxi Zhendong Ante Biopharmaceutical Co., Ltd. is located in Jinzhong Economic and Technological Development Zone, Shanxi Province. It is a high-tech enterprise mainly engaged in the research, development, production and sales of new drugs. The company is established. In October 1994, it was the largest foreign-invested joint-stock pharmaceutical enterprise in the province with a registered capital of 50 million yuan and more than 500 employees. In May 2011, Ante joined Zhendong and became a wholly-owned subsidiary of Zhendong Group. Since its establishment, Anteren adheres to the corporate purpose of "focusing on health and creating special effects", is brave in innovation and enterprising to make the company's due contribution to the development of Shanxi's economy and pharmaceutical industry, and has achieved good economic and social benefits. , has received widespread attention from all walks of life. The company has successively won Shanxi Province's May 1st Labor Certificate, Medal, and Collective First Class. In 2007, it was listed as a leading pharmaceutical enterprise in the "Eleventh Five-Year Plan" by the Shanxi Provincial Government. In terms of management, the company is committed to establishing a management system with "Ante characteristics" and creating a service-oriented management culture. The company pioneered the "SSI" management model, namely standardization, specialization and innovation. Clarify the responsibilities of each position, formulate standardized work processes and quantitative assessment standards, and point out the development direction of professionalism and innovation for each employee. The "SSI" management model reflects the organic combination of personal development and corporate development, and realizes human resources. Dynamic management of resources. Model innovation has exploded with tremendous energy. Under the overall downturn in the pharmaceutical industry, the company's performance growth rate exceeded 30% for three consecutive years, laying the foundation for the overall doubling of its performance next year and after. Culturally, the company is committed to the establishment of a corporate culture with a sense of justice, health and harmony. In three years, the company has completed the "focus on corporate interests, teamwork first, fair competition as the basis, and hard work and dedication. The shaping of Ante's moral culture, which is proud, strictly abides by institutional standards, and actively learns and innovates, has formed a cultural atmosphere of "professional first and active learning" throughout the company. At the same time, the company combines red culture with corporate culture and gives full play to the Party organizations and trade unions play the role of enterprises, inherit and learn from the Party’s fine traditions, and give full play to the vanguard and exemplary role of Party members in employees. In team building, implement the strategy of developing enterprises with talents and create an atmosphere of "respecting talents and utilizing talents" throughout the company. The company firmly believes in the value of each employee in the company, attaches importance to the cultivation of employees at different stages of development, and manages with "SSI" Based on the model, we will improve the supporting human resources assessment system and design a career development path that is compatible with the growth of the company for employees. Complex talents of knowledge-based and professional-based have become the main force in Ante's development and construction. In terms of products, after years of operation, the company has formed four series of products, including heart, brain, nerve, and external use, mainly for gastrointestinal drugs, with eight national new drugs, among which "colloidal pectin bismuth capsules" are well sold nationwide and have accumulated sales With over 10 billion yuan, "Ante brand colloidal pectin bismuth capsules" were rated as a famous trademark in Shanxi Province; "Basalanol tablets" fill the gap in the field of drug use in ulcerative colitis in China and are included in the national torch plan project; "Safflower Injection" has been guaranteed through process innovation, and its sales doubled year by year. The company has become the largest safflower injection production and sales enterprise in the country. In terms of R&D, the company is committed to the research and development of innovative drugs with "independent knowledge" property rights. With the provincial technology center as a platform, it has a complete R&D system, and has a professional team specializing in pharmaceutical research and product development. The well-known domestic institutes maintain extensive and in-depth cooperative relationships. At present, the company's two independent innovation projects, "Compound Colloidal Bismuth Pectin Preparation" and "Basalanolene Enema Preparation", have obtained national patents and entered the stage of new drug research and development, among which compound colloid Bismuth pectin preparation is a new national first-class drug. Products under development have become the driving force for the company's re-development. In marketing, the company adheres to the marketing strategy of parallel development of clinical and retail, based on the advantages of "clinical" and aims at the development laws of different stages of the product, the company has completed the "academic" core in three years, with the product from clinical to OCT The product marketing strategy layout for market transfer. The company has offices in 30 provinces, autonomous regions and municipalities across the country. It has a high-quality professional marketing team and has stable construction with more than 1,000 hospitals and top 20 well-known businesses in China. Partnership, nearly a thousand experts provide academic support to the company. In terms of production, the company has built a modern pharmaceutical production base that complies with GMP standards. All facilities and equipment have reached the leading level in China, including capsules, tablets, granules, gels, solutions, small-solution injections and raw materials A complete and reasonable product dosage form for the drug production line. The era of great development of medicine has arrived. For Ante, his career has just begun. We are full of confidence in the future of the company. Our goal is to "create Ante's century-old enterprise and create the first brand of the national digestive tract."